Personal information

viruses, vaccines, evolution, immunology, pathology

Biography

I am the Professor of Comparative Pathology at the University of Cambridge and Head of the Lab of Viral Zoonotics (LVZ) and a Fellow and former vice Master of Darwin College. I study viruses that are transmitted from animals to humans (Zoonotic Viruses) that have the potential to cause high consequence human disease outbreaks. My expertise is in Viral disease, Immunology and Vaccine development. A detailed understanding of the deleterious versus protective immune responses to RNA viruses enables us to design safer vaccines with broader protection for prevention and control from highly variable RNA viruses. Research at the LVZ spans human and veterinary medicine as we trace the origins and evolution of pathogens and their hosts. In 2017 we established new technology to make vastly improved vaccine antigens, and spun-out DIOSynVax Ltd out of Cambridge to deliver NextGen vaccine antigens for vaccines to prevent future pandemics.

Activities

Employment (1)

University of Cambridge: Cambridge, Cambridgeshire, GB

2007-02-01 to present | Professor of Comparative Pathology (Department of Veterinary Medicine)
Employment
Source: Self-asserted source
Jonathan Luke Heeney

Education and qualifications (8)

Royal College of Veterinary Surgeons: London, GB

2023-08-01 to present | Fellow
Qualification
Source: Self-asserted source
Jonathan Luke Heeney

Darwin College, University of Cambridge: Cambridge, GB

2011-01-01 to present | Fellow
Qualification
Source: Self-asserted source
Jonathan Luke Heeney

University of Cambridge: Cambridge, Cambridgeshire, GB

2007-02-01 to 2012-06-01 | ScD
Education
Source: Self-asserted source
Jonathan Luke Heeney

University of Cambridge: Cambridge, Cambridgeshire, GB

2007-02-01 to 2007-12-30 | MA
Education
Source: Self-asserted source
Jonathan Luke Heeney

National Institutes of Health / University of Guelph: Bethesda, MD, US

1986-01-01 to 1989-01-30 | PhD
Education
Source: Self-asserted source
Jonathan Luke Heeney

University of Guelph: Guelph, ON, CA

1984-06-01 to 1986-12-30 | DVSc(Path) (Department of Pathology)
Education
Source: Self-asserted source
Jonathan Luke Heeney

University of Guelph: Guelph, ON, CA

1980-09-01 to 1984-05-31 | DVM (Ontario Veterinary College)
Education
Source: Self-asserted source
Jonathan Luke Heeney

University of Guelph: Guelph, ON, CA

1977-05-01 to 1980-05-30 | BSc Biology
Education
Source: Self-asserted source
Jonathan Luke Heeney

Professional activities (5)

The Canada-UK Foundation: London, GB

2013-01-01 to present | Trustee
Invited position
Source: Self-asserted source
Jonathan Luke Heeney

Eurovacc Foundation: Lausanne, CH

2000-01-01 to present | Trustee & Founding Board member
Invited position
Source: Self-asserted source
Jonathan Luke Heeney

Biotechnology and Biological Sciences Research Council: Swindon, GB

2016-01-01 to 2023-01-01 | Member
Invited position
Source: Self-asserted source
Jonathan Luke Heeney

Jenner Institute: Oxford, England, GB

2012-01-01 to 2023-01-01 | Chairperson, Scientific Advisory Board
Invited position
Source: Self-asserted source
Jonathan Luke Heeney

Imperial College London Faculty of Medicine: London, London, GB

2017-01-01 | External Examiner in Molecular Virology (Medicine)
Distinction
Source: Self-asserted source
Jonathan Luke Heeney

Funding (13)

mRNA delivered multi-antigen broadly protective Betacoronavirus vaccine

Investigation of proven vaccine breakthrough by SARS-CoV-2 variants in established UK healthcare worker cohorts: SIREN consortium & PITCH Plus Pathway

2021-08-12 to 2023-02-12 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/W02067X/1
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Immunogenicity of a Trivalent Vaccine Candidate against Lassa Fever, Ebola, and Marburg virus

2020-09-30 to 2024-03-31 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: 2644873
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Development of a Universal Influenza Vaccine using Digital Immune Optimising Synthetic Vaccine Antigens (DIOSynVax)

Source: Self-asserted source
Jonathan Luke Heeney

Lassa outbreak response: early intervention and community response capacity in Ondo, Edo and Ebonyi states, Nigeria

2019-07-01 to 2021-01-01 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

216619/Z/19/Z

Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Digital Immune Optimized and Selected Pan-Influenza Vaccine Antigens (DIOS-PIVa)

2019-03-31 to 2022-12-31 | Grant
Innovate UK (Swindon, GB)
GRANT_NUMBER: 105078
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Clinical trial of a DIOS Trivalent Haemorrhagic Fever Vaccine (DIOS-HFVac3)

2018-08-31 to 2020-08-30 | Grant
Innovate UK (Swindon, GB)
GRANT_NUMBER: 971616
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

One Health and accelerating Vaccines for Ebola and Lassa (OVEL)

2018-04-30 to 2021-03-30 | Grant
Biotechnology and Biological Sciences Research Council (Swindon, GB)
GRANT_NUMBER: BB/R020116/1
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Trivalent Lassa, Ebola and Marburg viral vaccine (Tri-LEMvac)

2017-03-31 to 2018-05-30 | Grant
Innovate UK (Swindon, GB)
GRANT_NUMBER: 971511
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Emerging Viral Vaccine Antigen Insert Consortium (EVAC)

2016-08-31 to 2017-10-31 | Grant
Innovate UK (Swindon, GB)
GRANT_NUMBER: 972226
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Optimising transcriptome subtraction technology to identify complicating infections in human hepatitis.

2010-12-01 to 2016-04-30 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

091501/Z/10/Z

Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Targeting Neutralizing Epitopes in the HIV Envelope

2006-09-20 to 2013-08-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: P01AI066287
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Multi-component HIV Vaccines Using Engineered Envelopes

2002-09-30 to 2006-07-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: P01AI048225
Source: Self-asserted source
Jonathan Luke Heeney via DimensionsWizard

Peer review (1 review for 1 publication/grant)

Review activity for npj vaccines. (1)